Stay updated on CV301-Nivolumab Combo in Metastatic CRC Clinical Trial

Sign up to get notified when there's something new on the CV301-Nivolumab Combo in Metastatic CRC Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the CV301-Nivolumab Combo in Metastatic CRC Clinical Trial page

  1. Check
    today
    No Change Detected
  2. Check
    yesterday
    No Change Detected
  3. Check
    2 days ago
    Change Detected
    Summary
    The value of Revision has been updated from v2.8.0 to v2.8.1, indicating a recent revision in the content of the webpage.
    Difference
    0.1%
    Check dated 2024-06-13T21:18:21.000Z thumbnail image
  4. Check
    4 days ago
    No Change Detected
  5. Check
    5 days ago
    No Change Detected
  6. Check
    10 days ago
    Change Detected
    Summary
    The value 7 has recently changed to 8 on the webpage. This change represents an update in a multi-center Phase II randomized study involving perioperative CV301 vaccination in combination with Nivolumab and systemic chemotherapy for resectable hepatic-limited metastatic colorectal cancer.
    Difference
    0.1%
    Check dated 2024-06-06T14:24:05.000Z thumbnail image
  7. Check
    25 days ago
    Change Detected
    Summary
    The 'Participation Criteria 6' section has been updated to 'Participation Criteria Researchers look for people who fit a certain description, called eligibility criteria,' providing examples such as general health condition or prior treatments. Additionally, the 'Eligibility Criteria Description' now includes detailed inclusion and exclusion criteria for study participants.
    Difference
    43%
    Check dated 2024-05-22T20:23:01.000Z thumbnail image
  8. Check
    46 days ago
    Change Detected
    Summary
    The value 'Go to the classic website Go to the classic website 5 2' on the webpage has been updated to 'Site Map 6 0', indicating a change related to the type of intervention, possibly concerning medical and healthcare-related publications and documentation.
    Difference
    0.8%
    Check dated 2024-05-01T17:33:38.000Z thumbnail image

Stay in the know with updates to CV301-Nivolumab Combo in Metastatic CRC Clinical Trial

Enter your email address, and we'll notify you when there's something new on the CV301-Nivolumab Combo in Metastatic CRC Clinical Trial page.